Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Journal of Nephrology|December 29, 2010
Management of secondary hyperparathyroidism in Italy: results of the Italian FARO surveySandro Mazzaferro, Diego Brancaccio, Piergiorgio Messa, et al.
International Journal of Nephrology and Renovascular Disease|January 8, 2015
Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 studyDaniela Paola Roggeri, Mario Cozzolino, Sandro Mazzaferro, et al.
The Lancet. Diabetes & Endocrinology|October 21, 2017
Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general populationAdrian Covic, Marc Vervloet, Ziad A Massy, et al.
Journal of Translational Medicine|November 27, 2019
Renal involvement and metabolic alterations in adults patients affected by cystic fibrosisSilvia Lai, Sandro Mazzaferro, Anna Paola Mitterhofer, et al.
Kidney International Reports|May 20, 2024
Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the DOPPSSuguru Yamamoto, Hanne Skou Jørgensen, Junhui Zhao, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paperPieter Evenepoel, Patrick D'Haese, Justine Bacchetta, et al.
Blood Purification|June 1, 2011
Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortalityDiego Brancaccio, Mario Cozzolino, Giuseppe Cannella, et al.
Clinical Kidney Journal|September 29, 2015
Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet)Vincent Brandenburg, Teresa Adragao, Bastiaan van Dam, et al.
Blood Purification|October 4, 2014
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: results of the FARO-2 cohortMario Cozzolino, Piergiorgio Messa, Diego Brancaccio, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 16, 2019
Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapySilvia Lai, Maurizio Muscaritoli, Paola Andreozzi, et al.
Pageof 12